AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8821274 — intervention group
Group type: EXPERIMENTAL
Intervention: Early range of motion training in a Walker-Boot
Number of subjects: 40
Study 8821274 — intervention group
Group type: COMPARATOR
Intervention: Immobilization for 6 weeks in a plaster cast
Number of subjects: 40
Study 2084279 — intervention group
Group type: EXPERIMENTAL
Intervention: Abana
Number of subjects: 50
Study 2084279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 6938019 — intervention group
Group type: EXPERIMENTAL
Intervention: cytoxan and 5-FU
Number of subjects: 0
Study 6938019 — intervention group
Group type: EXPERIMENTAL
Intervention: estracyt or streptozotocin
Number of subjects: 0
Study 6938019 — intervention group
Group type: EXPERIMENTAL
Intervention: prednimustine and DTIC
Number of subjects: 0
Study 6938019 — intervention group
Group type: EXPERIMENTAL
Intervention: cytoxan and DES combined
Number of subjects: 0
Study 6938019 — intervention group
Group type: COMPARATOR
Intervention: methyl CCNU and hydroxyurea
Number of subjects: 0
Study 6938019 — intervention group
Group type: COMPARATOR
Intervention: estracyt or vincristine alone or in combination
Number of subjects: 0
Study 6938019 — intervention group
Group type: COMPARATOR
Intervention: cytoxan or estracyt
Number of subjects: 0
Study 31366352 — intervention group
Group type: EXPERIMENTAL
Intervention: Cashew apple juice (CAJ) at 3.5 mL/kgBM/day for 4 weeks
Number of subjects: 20
Study 31366352 — intervention group
Group type: EXPERIMENTAL
Intervention: Cashew apple juice (CAJ)
Number of subjects: 20
Study 27534738 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg once daily for 12 weeks
Number of subjects: 186
Study 27534738 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol CR/ZOK 47.5 mg once daily for 12 weeks
Number of subjects: 186
Study 27534738 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 186
Study 27534738 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 186
Study 27534738 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol CR/ZOK
Number of subjects: 186
Study 25994539 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation maintenance therapy with pemetrexed
Number of subjects: 0
Study 24135831 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 360 mg
Number of subjects: 60
Study 24135831 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 240 mg
Number of subjects: 60
Study 24135831 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg
Number of subjects: 60
Study 24135831 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg
Number of subjects: 60
Study 23230983 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological absence measured at the child's 36-month birthday-related assessment
Number of subjects: 2632
Study 19003731 — intervention group
Group type: EXPERIMENTAL
Intervention: Family systems therapeutic interventions
Number of subjects: 187
Study 19003731 — intervention group
Group type: COMPARATOR
Intervention: Control group (treated before team training)
Number of subjects: 187
Study 17200357 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐12 at 30 ng/kg with alum (group A)
Number of subjects: 60
Study 17200357 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐12 at 100 ng/kg with alum (group B)
Number of subjects: 60
Study 17200357 — intervention group
Group type: COMPARATOR
Intervention: IL‐12 at 30 ng/kg with 250 mug GM‐CSF (group C)
Number of subjects: 60
Study 17200357 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-vaccine immune response to MART‐1
Number of subjects: 60
Study 15627154 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% diclofenac sodium (Naclof) eye drops
Number of subjects: 26
Study 15627154 — intervention group
Group type: COMPARATOR
Intervention: 1% prednisolone acetate eye suspension
Number of subjects: 26
Study 12355941 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal therapy involving intravesical instillation after transurethral resection for superficial bladder cancer
Number of subjects: 102
Study 9747867 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of L-phenylalanine mustard, 5-fluorouracil, and doxorubicin (PAF)
Number of subjects: 638
Study 9747867 — intervention group
Group type: COMPARATOR
Intervention: L-phenylalanine mustard plus 5-fluorouracil (PF)
Number of subjects: 638
Study 8010083 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofl tablets evaluated by NONMEM
Number of subjects: 12
Study 8010083 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofl tablets evaluated by standard approach
Number of subjects: 12
Study 8010083 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofl tablets evaluated by NONMEM with sparse clinical data
Number of subjects: 12
Study 2061447 — intervention group
Group type: EXPERIMENTAL
Intervention: Spot dermabrasion ('scarabrasion') on the left half of each scar
Number of subjects: 48
Study 2061447 — intervention group
Group type: COMPARATOR
Intervention: Untreated right half of each scar (control)
Number of subjects: 48
Study 347459 — intervention group
Group type: EXPERIMENTAL
Intervention: CPC containing mouthwash
Number of subjects: 41
Study 347459 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 41
Study 30301963 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Watchers® (WW) program
Number of subjects: 292
Study 30301963 — intervention group
Group type: COMPARATOR
Intervention: Self-help (SH) condition
Number of subjects: 292
Study 27630253 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (IBTA) injection
Number of subjects: 50
Study 27630253 — intervention group
Group type: COMPARATOR
Intervention: Saline injection (placebo)
Number of subjects: 50
Study 25029009 — intervention group
Group type: EXPERIMENTAL
Intervention: SM: slow motivational songs, applied during 5 km of running
Number of subjects: 15
Study 25029009 — intervention group
Group type: EXPERIMENTAL
Intervention: FM: fast and motivational songs, applied during 5 km of running
Number of subjects: 15
Study 25029009 — intervention group
Group type: EXPERIMENTAL
Intervention: PM: motivational songs, applied before 5 km of running
Number of subjects: 15
Study 25029009 — intervention group
Group type: EXPERIMENTAL
Intervention: CS: calm songs, applied after 5 km of running
Number of subjects: 15
Study 23948540 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alcohol administration
Number of subjects: 32
Study 21576654 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation (CR) participation (40% of cohort, 964 of 2395)
Number of subjects: 2395
Study 19814624 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (7vPnC)
Number of subjects: 599
Study 19814624 — intervention group
Group type: COMPARATOR
Intervention: 23-valent polysaccharide vaccine (PPV)
Number of subjects: 599
Study 18581096 — intervention group
Group type: EXPERIMENTAL
Intervention: Opiate antagonists (nalmefene 50 or 100 mg/day or naltrexone 100 or 150 mg/day)
Number of subjects: 284
Study 18581096 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 284
Study 15024667 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance protocol
Number of subjects: 6
Study 15024667 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate interval protocol
Number of subjects: 6
Study 15024667 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance protocol
Number of subjects: 6
Study 11816482 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg doxorubicin
Number of subjects: 465
Study 11816482 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg epirubicin
Number of subjects: 465
Study 11816482 — intervention group
Group type: COMPARATOR
Intervention: No instillation
Number of subjects: 465
Study 9839100 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group A (lispro and NPH injected separately)
Number of subjects: 12
Study 9839100 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group B (lispro and NPH mixed in syringe)
Number of subjects: 12
Study 9839100 — intervention group
Group type: COMPARATOR
Intervention: Treatment group C (human regular insulin and NPH mixed)
Number of subjects: 12
Study 8135432 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm buffered lidocaine
Number of subjects: 32
Study 8135432 — intervention group
Group type: COMPARATOR
Intervention: Warm lidocaine
Number of subjects: 32
Study 8135432 — intervention group
Group type: COMPARATOR
Intervention: Buffered lidocaine
Number of subjects: 32
Study 8135432 — intervention group
Group type: COMPARATOR
Intervention: Room-temperature unbuffered lidocaine
Number of subjects: 32
Study 2783702 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (up to 75 mg/day)
Number of subjects: 12
Study 2783702 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (up to 40 mg/day)
Number of subjects: 12
Study 2783702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2783702 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (measured dose)
Number of subjects: 12
Study 977751 — intervention group
Group type: EXPERIMENTAL
Intervention: One-word verbal reinforcement (VR)
Number of subjects: 30
Study 977751 — intervention group
Group type: EXPERIMENTAL
Intervention: Lengthy verbal information feedback (IF)
Number of subjects: 30
Study 977751 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 12014128 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture treatment for 4 weeks
Number of subjects: 86
Study 12014128 — intervention group
Group type: COMPARATOR
Intervention: Control group with clinical treatment plus active and/or passive functional exercise
Number of subjects: 86
Study 31069191 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimotuzumab plus CRT
Number of subjects: 29
Study 31069191 — intervention group
Group type: COMPARATOR
Intervention: CRT alone
Number of subjects: 29
Study 29222139 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (150 mg daily)
Number of subjects: 95
Study 29222139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 26901237 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infiltration of local anesthetic at the nephrostomy site
Number of subjects: 60
Study 26901237 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic injected only once
Number of subjects: 60
Study 26901237 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline injected as a control
Number of subjects: 60
Study 24965303 — intervention group
Group type: EXPERIMENTAL
Intervention: exendin(9-39)NH2 (ex9-39) intravenous infusion
Number of subjects: 10
Study 24965303 — intervention group
Group type: COMPARATOR
Intervention: saline intravenous infusion
Number of subjects: 10
Study 22364402 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting methylphenidate formulation (MPH-ret)
Number of subjects: 36
Study 22364402 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release methylphenidate (MPH-IR)
Number of subjects: 36
Study 22364402 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 36
Study 20585297 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low-Carbohydrate Diet (VLCD) (<40 g carbohydrate; n=12)
Number of subjects: 24
Study 20585297 — intervention group
Group type: COMPARATOR
Intervention: Conventional Diet (CONV) (500 to 800 kcal; n=12)
Number of subjects: 24
Study 17579542 — intervention group
Group type: EXPERIMENTAL
Intervention: Active listening and collaborative problem-solving models
Number of subjects: 2611
Study 17579542 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality assurance and standardized practices recommendations
Number of subjects: 2611
Study 16376739 — intervention group
Group type: EXPERIMENTAL
Intervention: MCO home visits
Number of subjects: 250
Study 16376739 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Karnofsky Index (KI)
Number of subjects: 250
Study 16376739 — intervention group
Group type: COMPARATOR
Intervention: General characteristics (age, gender, rural or urban residence, disease)
Number of subjects: 250
Study 16376739 — intervention group
Group type: COMPARATOR
Intervention: Type of care at referral (chemotherapy, palliative care, or other supportive care)
Number of subjects: 250
Study 12075144 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal Vision (NV)
Number of subjects: 11
Study 12075144 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Vision (LV)
Number of subjects: 11
Study 9869235 — intervention group
Group type: EXPERIMENTAL
Intervention: 192Ir
Number of subjects: 0
Study 9869235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8584183 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental scanning of visual images generated from verbal descriptions; specific sequencing of descriptions (continuous vs. discontinuous)
Number of subjects: 0
Study 8584183 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative model of image elaboration
Number of subjects: 0
Study 8584183 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer program simulating mental scanning protocol
Number of subjects: 0
Study 2765334 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam + Methohexitone
Number of subjects: 60
Study 2765334 — intervention group
Group type: COMPARATOR
Intervention: Methohexitone alone
Number of subjects: 60
Study 2765334 — intervention group
Group type: COMPARATOR
Intervention: Midazolam alone
Number of subjects: 60
Study 975978 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-percent solution of metaproterenol sulfate (Alupent)
Number of subjects: 27
Study 975978 — intervention group
Group type: COMPARATOR
Intervention: 0.5-percent solution of isoproterenol
Number of subjects: 27
Study 975978 — intervention group
Group type: EXPERIMENTAL
Intervention: metaproterenol therapy
Number of subjects: 27
Study 975978 — intervention group
Group type: EXPERIMENTAL
Intervention: metaproterenol
Number of subjects: 27
Study 30586747 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR) using SAPIEN XT valve (XT-TAVR)
Number of subjects: 3110
Study 30586747 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR) using SAPIEN 3 valve (S3-TAVR)
Number of subjects: 3110
Study 30586747 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 3110
Study 30586747 — intervention group
Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 3110
Study 28145956 — intervention group
Group type: EXPERIMENTAL
Intervention: Hallux valgus group
Number of subjects: 20
Study 27297375 — intervention group
Group type: EXPERIMENTAL
Intervention: Family empowerment program (4 counselling dialogues)
Number of subjects: 65
Study 27297375 — intervention group
Group type: COMPARATOR
Intervention: Traditional care in asthma clinics
Number of subjects: 65
Study 25060104 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproductive health program consisting of reproductive health education, health counseling, phone monitoring, and emotional support implemented for four weeks
Number of subjects: 58
Study 25060104 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 58
Study 22492922 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Fascial Taping
Number of subjects: 43
Study 22492922 — intervention group
Group type: COMPARATOR
Intervention: Placebo Taping
Number of subjects: 43
Study 19535431 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating with a friend
Number of subjects: 65
Study 19535431 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating with an overweight partner (friend or unfamiliar peer)
Number of subjects: 65
Study 19535431 — intervention group
Group type: COMPARATOR
Intervention: Eating with an unfamiliar peer
Number of subjects: 65
Study 17463141 — intervention group
Group type: EXPERIMENTAL
Intervention: OIENS + glyc
Number of subjects: 74
Study 17463141 — intervention group
Group type: EXPERIMENTAL
Intervention: OIENS
Number of subjects: 74
Study 17463141 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 74
Study 17463141 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 74
Study 14695785 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (CIM) administered perioperatively, starting 7 days before surgery and continuing for 10 days after surgery.
Number of subjects: 49
Study 14695785 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cimetidine treatment).
Number of subjects: 49
Study 14695785 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (CIM) treatment.
Number of subjects: 49
Study 11336170 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha alone (3 MU tiw) or in combination with ribavirin for 6-12 months
Number of subjects: 25
Study 11336170 — intervention group
Group type: COMPARATOR
Intervention: Control group (age- and gender-matched)
Number of subjects: 25
Study 9203615 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive vein harvest technique (group 1)
Number of subjects: 30
Study 9203615 — intervention group
Group type: COMPARATOR
Intervention: Standard method (group 2)
Number of subjects: 30
Study 7956281 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin (6.0 +/- 0.3 IU/kg/hr)
Number of subjects: 46
Study 7956281 — intervention group
Group type: EXPERIMENTAL
Intervention: PGI2 (7.7 +/- 0.7 ng/kg/min)
Number of subjects: 46
Study 7956281 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PGI2 (6.4 +/- 0.3 ng/kg/min) and Heparin (5.0 +/- 0.4 IU/kg/hr)
Number of subjects: 46
Study 7956281 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 46
Study 2884759 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodilution (venesection and infusion of dextran 40)
Number of subjects: 1200
Study 2884759 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment provided by each center
Number of subjects: 1200
Study 30441289 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuzzy Logic Controller (FLC) for cycling performance measurement
Number of subjects: 15
Study 27930455 — intervention group
Group type: EXPERIMENTAL
Intervention: 4vs4+2IW+2IEW-NO
Number of subjects: 22
Study 27930455 — intervention group
Group type: EXPERIMENTAL
Intervention: 4vs4+2IW+2IEW-GK
Number of subjects: 22
Study 27930455 — intervention group
Group type: COMPARATOR
Intervention: 4vs4-NO
Number of subjects: 22
Study 27930455 — intervention group
Group type: COMPARATOR
Intervention: 4vs4+2IW-NO
Number of subjects: 22
Study 27930455 — intervention group
Group type: COMPARATOR
Intervention: 4vs4-GK
Number of subjects: 22
Study 25385705 — intervention group
Group type: EXPERIMENTAL
Intervention: Any binge eating
Number of subjects: 392
Study 25385705 — intervention group
Group type: COMPARATOR
Intervention: Never binge eating
Number of subjects: 392
Study 25385705 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency binge eating
Number of subjects: 392
Study 23157922 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemia Index
Number of subjects: 55
Study 21520442 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular physical participation (Group B)
Number of subjects: 18
Study 21520442 — intervention group
Group type: COMPARATOR
Intervention: Sedentary (Group A)
Number of subjects: 18
Study 18067517 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD training (endurance training at 85% of VO(2max) twice weekly for 7 weeks plus daily home-based training)
Number of subjects: 19
Study 18067517 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD training
Number of subjects: 19
Study 18067517 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 19
Study 16689001 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiangtang Bushen Recipe (JBR), one dose a day for 4 weeks
Number of subjects: 64
Study 16689001 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiangtang Bushen Recipe (JBR)
Number of subjects: 64
Study 16689001 — intervention group
Group type: COMPARATOR
Intervention: Control group (education course, dietary treatment, and conventional hypoglycemic agent)
Number of subjects: 64
Study 12656692 — intervention group
Group type: EXPERIMENTAL
Intervention: VSL#3 (450 billion lyophilized bacteria/day)
Number of subjects: 25
Study 12656692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 12656692 — intervention group
Group type: EXPERIMENTAL
Intervention: VSL#3
Number of subjects: 25
Study 10720511 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with zidovudine and didanosine with or without nevirapine
Number of subjects: 57
Study 10720511 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 57
Study 10720511 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine
Number of subjects: 57
Study 10720511 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine
Number of subjects: 57
Study 9178167 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole 50 mg daily
Number of subjects: 844
Study 9178167 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole 100 mg daily
Number of subjects: 844
Study 9178167 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole 200 mg daily
Number of subjects: 844
Study 9178167 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole (all dosages)
Number of subjects: 844
Study 9178167 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole Early Access Program
Number of subjects: 844
Study 8499208 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (total dose 3.2 (SEM 0.3) mg kg‐1 h‐1)
Number of subjects: 16
Study 8499208 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam (total dose 15 (2) micrograms kg‐1 h‐1)
Number of subjects: 16
Study 2961355 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate 1.6 g/day
Number of subjects: 34
Study 2961355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 30168759 — intervention group
Group type: EXPERIMENTAL
Intervention: Short femoral stem (MiniHip)
Number of subjects: 53
Study 30168759 — intervention group
Group type: COMPARATOR
Intervention: Conventional femoral stem (MetaFix)
Number of subjects: 53
Study 27923381 — intervention group
Group type: EXPERIMENTAL
Intervention: ARTES (parenteral artesunate at 2.4 mg/kg at H0, H12, H24 and then once daily)
Number of subjects: 0
Study 27923381 — intervention group
Group type: COMPARATOR
Intervention: QLD (loading dose of quinine base at 16.6 mg/kg followed 8 h later by an 8-hourly maintenance dose of 8.3 mg/kg quinine base)
Number of subjects: 0